APFED Welcomes Deborah Bruner to its Board of Directors

For immediate release

APFED Welcomes Deborah Bruner to its Board of Directors
Long-time Advocate Joins Board of Eosinophil-Associated Diseases Nonprofit

ATLANTA, GA, October 2024—The Board of Directors of the American Partnership for Eosinophilic Disorders (APFED) announces the appointment of new board secretary Deborah Bruner, MT, MBA. Mrs. Bruner will play a key part in organizing communications among APFED’s board, shaping APFED’s strategic initiatives, and representing APFED and the patient voice as we work together with the Consortium of Eosinophilic Gastrointestinal Disease Researchers (rdcrn.org/cegir) to advance these diseases.

Mrs. Bruner has had a successful career spanning nearly 40 years. An accomplished leader in the pharmaceutical industry with diverse background in clinical, regulatory, safety and product development, she has been recognized for cultural and global insight, analytical skills, and effective team-building.

Mrs. Bruner also has first-hand experience with eosinophil-associated disease, having lived a number of years with eosinophilic esophagitis and eosinophilic asthma. She has publicly shared her experiences with these conditions to patients, families, clinicians and researchers to foster a better understanding of the impacts.

“As a new member of APFED’s board, I am truly excited to contribute to the organization’s mission. I look forward to working collaboratively with my fellow board members to drive innovation, make strategic decisions, and support the organization’s growth. Together, I believe we can make a meaningful impact and achieve great things,” Mrs. Bruner shares.

“We are excited to welcome Deb Bruner to our Board of Directors,” said APFED President Dr. Wendy Book. “Her extensive experience and visionary leadership will be invaluable as we continue to grow, expand, and provide impactful programs and services designed to help people who live with eosinophil-associated disease.”

About APFED
Founded in 2001, the American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization dedicated to patients and their families coping with eosinophilic disorders. APFED’s mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.
www.apfed.org